GO:0004346 glucose-6-phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004346 glucose-6-phosphatase activity describes the hydrolysis of D-glucose 6-phosphate to free D-glucose and inorganic phosphate, the terminal step of endogenous glucose production.
• The catalytic component is a microsomal enzyme whose activity is strongly influenced by the membrane environment and by transporter proteins that deliver substrate.
• Glucose-6-phosphatase activity is central to blood glucose homeostasis and is regulated nutritionally in opposition to glucokinase.
• Altered glucose-6-phosphatase expression and activity are observed in metabolic, inflammatory, and malignant tissues, where they influence glucose handling and tracer retention.
• Hormonal and dietary signals, including glucocorticoids and microbiota-derived metabolites, modulate glucose-6-phosphatase activity in liver and islets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal dissection of glucose-6-phosphatase genes in metabolic and cancer biology.
Description
Glucose-6-phosphatase activity (GO:0004346) is the enzymatic function that removes the phosphate group from D-glucose 6-phosphate, releasing free D-glucose and inorganic phosphate. This reaction is the final common step of both glycogenolysis and gluconeogenesis, and it is therefore a decisive control point for endogenous glucose production. The activity is classically associated with the liver, kidney, and pancreatic islets, where it helps maintain blood glucose within a narrow physiological range. Because the substrate and product are central metabolites, the reaction also intersects with glycolytic and pentose-phosphate pathways, making it relevant far beyond classical glucose homeostasis. At the molecular level, glucose-6-phosphatase activity is not a single soluble enzyme but depends on a microsomal catalytic unit and on membrane-associated transport functions that supply the substrate and remove the products. This arrangement means that measured activity reflects both the catalytic protein and the integrity of the endoplasmic reticulum membrane. Researchers study this term to understand metabolic disease, to interpret glucose tracer imaging, and to define how tissues switch between glucose storage and glucose release. In practical research settings, glucose-6-phosphatase activity is quantified in tissue homogenates, islets, and cultured cells, and it is increasingly linked to gene expression programs in inflammation and cancer. The availability of CRISPR models now makes it possible to test whether specific genes are causally required for the activity rather than merely correlated with it.
glucose-6-phosphatase activity At A Glance
| GO ID | GO:0004346 |
|---|---|
| GO term | glucose-6-phosphatase activity |
| Ontology | molecular_function |
| Synonym | D-glucose-6-phosphate phosphohydrolase activity; glucose 6-phosphate phosphatase activity |
| Definition | Catalysis of the reaction D-glucopyranose 6-phosphate + H2O = D-glucose + phosphate |
| Major function | Terminal dephosphorylation step of endogenous glucose production |
| Substrate | D-glucose 6-phosphate |
| Products | D-glucose and phosphate |
| Cellular context | Microsomal membrane-associated enzyme system |
| Related regulation | Nutritional and hormonal control opposing glucokinase |
What Is GO:0004346?
GO:0004346 glucose-6-phosphatase activity is defined as catalysis of the reaction D-glucopyranose 6-phosphate plus water yielding D-glucose plus phosphate, where D-glucopyranose 6-phosphate is also known as D-glucose 6-phosphate. In other words, it is the phosphohydrolase activity that dephosphorylates glucose 6-phosphate, and it is synonymous with D-glucose-6-phosphate phosphohydrolase activity and glucose 6-phosphate phosphatase activity.
Why Is glucose-6-phosphatase activity Important in Cell Biology?
Glucose-6-phosphatase activity is important because it determines whether glucose 6-phosphate is retained for intracellular metabolism or released as free glucose to the circulation, thereby controlling systemic glucose supply. Its dysregulation is linked to metabolic pathology, and its expression influences how tissues handle glucose tracers used in imaging and diagnostics. Because the activity depends on membrane-associated components, it also serves as a model for studying how membrane environment and transport shape enzyme function.
• Controls the final step of hepatic glucose output and thus blood glucose homeostasis.
• Provides the biochemical basis for understanding glycogen storage and gluconeogenic disorders.
• Is nutritionally regulated in opposition to glucokinase, defining the liver's glucose sensor set point.
• Is modulated by glucocorticoids in pancreatic islets, linking stress hormones to islet glucose handling.
• Is influenced by gut microbiota-derived metabolites through gut-brain neural circuits.
• Contributes to glucose-6-phosphate hydrolysis that affects FDG tracer efflux in inflammation and cancer.
• Correlates with malignancy grade in ovarian tumors when linked to hexokinase activity.
• Requires an intact microsomal membrane and transport functions for full activity.
• Serves as a target for mechanistic studies of metabolic disease and cancer metabolism.
• Enables CRISPR-based causal testing of candidate metabolic genes.
Molecular Mechanism of glucose-6-phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme must first grab glucose 6-phosphate, the sugar with a phosphate attached.
Glucose-6-phosphatase activity acts on D-glucose 6-phosphate, the phosphorylated form of glucose, and the reaction releases free glucose plus phosphate. Because the substrate is hydrophilic and the catalytic site is associated with the endoplasmic reticulum membrane, substrate access depends on membrane-associated transport components that deliver glucose 6-phosphate to the catalytic unit. This arrangement means that substrate recognition is coupled to membrane topology rather than occurring in free solution.
Catalytic hydrolysis
In simple terms: The enzyme cuts the phosphate off the sugar using water.
The catalytic event is a hydrolysis reaction in which water attacks the phosphate ester of D-glucose 6-phosphate, yielding D-glucose and inorganic phosphate. The reaction is classified as a phosphohydrolase activity, and it is synonymous with glucose 6-phosphate phosphatase activity. The catalytic unit is a microsomal protein, and its activity is measured as the release of phosphate or glucose from glucose 6-phosphate in tissue preparations.
Membrane dependence and transport coupling
In simple terms: The enzyme works as part of a membrane machine, not as a lone protein.
The activity of microsomal glucose-6-phosphatase is regulated by the membrane in which it resides, and disruption of the membrane alters catalytic behavior. Transmembrane topology studies show that the catalytic protein spans the endoplasmic reticulum membrane, consistent with a model in which separate transporter proteins supply substrate and remove products. Consequently, assays of glucose-6-phosphatase activity reflect both the catalytic protein and the functional integrity of the microsomal transport system.
Nutritional and hormonal regulation
In simple terms: The enzyme is switched on or off depending on what the body has recently eaten and on hormone signals.
Glucose-6-phosphatase activity is nutritionally regulated in a reciprocal manner with glucokinase, so that the liver releases glucose when needed and stores it when glucose is abundant. Glucocorticoid treatment changes glucose-6-phosphatase activity in pancreatic islets, indicating that stress hormones directly modulate the activity in endocrine tissue. Microbiota-generated metabolites can also promote metabolic benefits via gut-brain neural circuits, providing an indirect route by which diet-derived signals influence glucose handling.
Tissue-specific expression and disease association
In simple terms: Different tissues use this activity differently, and changes in it can accompany disease.
Glucose-6-phosphatase expression mediates FDG efflux in murine inflammation and cancer models, showing that the activity affects how much tracer remains in cells. Linked hexokinase and glucose-6-phosphatase activities reflect the grade of ovarian malignancy, suggesting that the balance between glucose trapping and release is clinically informative. In islets from obese and lean mice, glucose-6-phosphatase activity is measurable and responsive to dexamethasone, linking the activity to endocrine glucose sensing.
Key Genes Involved in GO:0004346 glucose-6-phosphatase activity
The following genes and proteins are directly or functionally associated with glucose-6-phosphatase activity (GO:0004346) in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| G6PC1 | Catalytic subunit of the microsomal glucose-6-phosphatase system | Core enzyme for endogenous glucose production and metabolic disease models |
| G6PC2 | Islet-specific glucose-6-phosphatase-related protein | Linked to islet glucose handling and dexamethasone response |
| G6PC3 | Ubiquitously expressed glucose-6-phosphatase catalytic subunit | Candidate for studying non-hepatic glucose-6-phosphate hydrolysis |
| SLC37A4 | Endoplasmic reticulum glucose-6-phosphate transporter | Required for substrate delivery to the catalytic unit |
| SLC37A1 | Putative glucose-6-phosphate transporter | Transport component of the microsomal system |
| SLC37A2 | Putative glucose-6-phosphate transporter | Transport component of the microsomal system |
| GCK | Glucokinase, opposing enzyme that phosphorylates glucose | Sets the reciprocal nutritional regulation with glucose-6-phosphatase |
| HK1 | Hexokinase 1, glucose phosphorylating enzyme | Linked activity with glucose-6-phosphatase in ovarian malignancy |
| HK2 | Hexokinase 2, glucose phosphorylating enzyme | Linked activity with glucose-6-phosphatase in cancer glucose metabolism |
| G6PD | Glucose-6-phosphate dehydrogenase, competing consumer of substrate | Determines fate of glucose 6-phosphate away from hydrolysis |
| PYGL | Glycogen phosphorylase, supplies glucose 6-phosphate from glycogen | Upstream contributor to substrate for glucose-6-phosphatase |
| PCK1 | Phosphoenolpyruvate carboxykinase, gluconeogenic enzyme | Upstream gluconeogenic pathway feeding glucose-6-phosphate |
| PCK2 | Mitochondrial phosphoenolpyruvate carboxykinase | Gluconeogenic pathway context for glucose-6-phosphatase activity |
| FOXO1 | Transcription factor regulating gluconeogenic genes | Candidate regulator of glucose-6-phosphatase expression |
| CREB1 | cAMP-responsive transcription factor | Hormonal regulation of glucose-6-phosphatase expression |
| NR3C1 | Glucocorticoid receptor | Mediates dexamethasone effects on islet glucose-6-phosphatase activity |
| INS | Insulin | Endocrine signal opposing glucose-6-phosphatase activity |
How Is glucose-6-phosphatase activity Regulated?
Glucose-6-phosphatase activity is regulated at multiple levels. Nutritionally, it is controlled reciprocally with glucokinase so that endogenous glucose production is suppressed after feeding and activated during fasting. Hormonally, glucocorticoids such as dexamethasone modify glucose-6-phosphatase activity in pancreatic islets, demonstrating direct endocrine control. The membrane environment is itself a regulatory factor, because the activity of microsomal glucose-6-phosphatase depends on the lipid and protein context of the endoplasmic reticulum. In addition, gut microbiota-derived metabolites can influence host glucose handling through gut-brain neural circuits, providing an indirect systemic regulatory route.
glucose-6-phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| G6PC1 | Glycogen storage disease and fasting hypoglycemia | Hepatocyte knockout and point-mutation models |
| G6PC2 | Islet glucose handling and glucocorticoid response | Islet-specific knockout and overexpression models |
| SLC37A4 | Microsomal transport defect mimicking catalytic loss | Transport-deficient knock-in models |
| HK2 | Ovarian malignancy grade and glucose metabolism | Cancer cell line knockout and overexpression |
| G6PC1 | FDG efflux in inflammation and cancer | Tumor and inflammation mouse models with tagged knock-in |
Metabolic and glycogen storage disorders
The molecular pathology of glucose-6-phosphatase is directly linked to inherited disorders of glucose homeostasis, because loss of the activity prevents normal release of glucose from glucose 6-phosphate. The enzyme system is also central to the nutritional regulation of endogenous glucose production, so its dysfunction contributes to fasting hypoglycemia and related metabolic phenotypes. Membrane and transporter defects can phenocopy catalytic defects because the activity requires an intact microsomal system.
Cancer metabolism and imaging
Glucose-6-phosphatase expression mediates FDG efflux in murine inflammation and cancer models, which means the activity can reduce tracer retention and confound imaging interpretation. Linked hexokinase and glucose-6-phosphatase activities reflect the grade of ovarian malignancy, indicating that the balance between glucose phosphorylation and dephosphorylation carries prognostic information. These findings make glucose-6-phosphatase activity a relevant variable in cancer metabolism studies.
Islet and endocrine dysfunction
Glucose-6-phosphatase activity is present in pancreatic islets and is altered by dexamethasone in both obese and lean mice, linking the activity to endocrine glucose sensing. Because islets must balance glucose oxidation and release, changes in glucose-6-phosphatase activity may influence insulin secretion and islet function. This makes islet glucose-6-phosphatase a candidate for studies of obesity and glucocorticoid excess.
Microbiota-host metabolic interactions
Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits, providing a host-level mechanism that can influence glucose handling and, indirectly, glucose-6-phosphatase activity. This positions the activity within the broader field of microbiome-host metabolic communication.
From glucose-6-phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is G6PC1 required for hepatic glucose release? | Constitutive or inducible G6PC1 knockout in hepatocytes |
| Does a catalytic residue mutation abolish glucose-6-phosphatase activity? | Point-mutation knock-in of the catalytic site |
| How does transporter loss affect activity? | SLC37A4 knockout or point-mutation models |
| Does islet glucose-6-phosphatase respond to glucocorticoids? | Islet-specific knockout with dexamethasone treatment |
| Does glucose-6-phosphatase expression alter FDG retention? | Overexpression and knockout in tumor or inflammation models |
| Is the hexokinase to glucose-6-phosphatase ratio prognostic? | Knockout and overexpression in ovarian cancer cell lines |
How to Study the glucose-6-phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphohydrolase assay | Phosphate or glucose release from glucose 6-phosphate | Liver and islet activity quantification |
| Microsomal membrane assay | Membrane-dependent catalytic activity | Testing membrane regulation of the enzyme |
| Transcript quantification | mRNA levels of glucose-6-phosphatase genes | Nutritional and hormonal regulation studies |
| FDG efflux measurement | Tracer retention and efflux | Inflammation and cancer imaging models |
| Paired hexokinase assay | Balance of glucose phosphorylation and dephosphorylation | Ovarian malignancy grading |
| Topology mapping | Membrane orientation of catalytic protein | Defining transport-coupled mechanism |
| Microbiota metabolite profiling | Host metabolic response to microbial products | Gut-brain metabolic studies |
Enzymatic activity assays
Glucose-6-phosphatase activity is classically measured by incubating tissue or microsomal preparations with glucose 6-phosphate and quantifying released phosphate or glucose. Because the activity depends on membrane integrity, assays must control for microsomal preparation quality. Islet and liver homogenates have been used to compare activity across genotypes and hormonal treatments.
Expression and transcript analysis
Expression of glucose-6-phosphatase genes is assessed by transcript quantification in liver, islets, and tumor samples to relate mRNA levels to measured activity. Nutritional and hormonal regulation studies compare expression before and after feeding or dexamethasone treatment. These analyses help distinguish transcriptional control from post-translational or membrane-dependent effects.
Tracer and imaging studies
FDG efflux studies in murine inflammation and cancer models reveal how glucose-6-phosphatase expression affects tracer retention. Linked hexokinase and glucose-6-phosphatase activity measurements have been used to grade ovarian malignancy, showing the value of paired enzymatic readouts. Such approaches connect molecular activity to whole-tissue imaging phenotypes.
Membrane topology and transport assays
Transmembrane topology analysis of glucose-6-phosphatase defines how the catalytic unit is oriented in the endoplasmic reticulum membrane. Membrane perturbation experiments show that the lipid environment regulates microsomal glucose-6-phosphatase activity. Together these methods define the transport-coupled mechanism of the activity.
How CRISPR Can Be Used to Study GO:0004346 glucose-6-phosphatase activity
Knockout
CRISPR knockout of glucose-6-phosphatase genes such as G6PC1 provides a direct test of whether the catalytic activity is required for glucose release in hepatocytes or islet cells. Knockout of transporter genes such as SLC37A4 can phenocopy catalytic loss and reveal the contribution of substrate delivery to measured activity. Knockout models are also used to determine whether glucose-6-phosphatase expression is necessary for FDG efflux in cancer and inflammation.
Point Mutation
Point-mutation knock-in of catalytic residues allows separation of catalytic activity from protein abundance and membrane insertion. Such models are valuable for testing whether a specific residue is essential for hydrolysis of glucose 6-phosphate. Point mutations in transporter genes can similarly distinguish transport defects from catalytic defects.
Knock-in
Tagged knock-in of glucose-6-phosphatase genes enables localization and interaction studies while preserving endogenous regulation. Knock-in of disease-associated variants can model the molecular pathology of glucose-6-phosphatase deficiency in relevant cell types. Knock-in approaches also support the study of islet-specific regulation by glucocorticoids.
Overexpression
Overexpression of glucose-6-phosphatase genes tests sufficiency for increased glucose release and altered tracer retention. In cancer cell lines, overexpression combined with hexokinase manipulation can probe the balance that correlates with malignancy grade. Overexpression in islet or liver models can reveal whether elevated activity is sufficient to change glucose handling.
How EDITGENE Supports glucose-6-phosphatase activity Research
Researchers studying glucose-6-phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in the activity or merely correlated with it, and this requires precise genome engineering rather than expression correlation alone. EDITGENE provides the cell models and screening services needed to move from association to causation in metabolic and cancer biology.
Contact EDITGENE today to design your custom CRISPR model for glucose-6-phosphatase activity research.
Frequently Asked Questions About glucose-6-phosphatase activity
What is glucose-6-phosphatase activity?
It is the enzymatic activity defined by GO:0004346 that hydrolyzes D-glucose 6-phosphate to D-glucose and phosphate, the terminal step of endogenous glucose production.
What reaction does GO:0004346 catalyze?
It catalyzes D-glucopyranose 6-phosphate plus water yielding D-glucose plus phosphate, where D-glucopyranose 6-phosphate is D-glucose 6-phosphate.
What genes are involved in glucose-6-phosphatase activity?
Key genes include G6PC1, G6PC2, G6PC3, and transporter genes such as SLC37A4, together with opposing enzymes like GCK and HK1 or HK2.
Where is glucose-6-phosphatase activity found in the cell?
It is a microsomal activity associated with the endoplasmic reticulum membrane, where transport components supply substrate to the catalytic unit.
How is glucose-6-phosphatase activity regulated?
It is regulated nutritionally in opposition to glucokinase and hormonally by glucocorticoids, and it also depends on the membrane environment.
Why is glucose-6-phosphatase activity important in cancer?
Glucose-6-phosphatase expression mediates FDG efflux in cancer models, and linked hexokinase and glucose-6-phosphatase activities reflect ovarian malignancy grade.
How do you measure glucose-6-phosphatase activity?
Activity is measured by incubating preparations with glucose 6-phosphate and quantifying released phosphate or glucose, with controls for microsomal membrane integrity.
Does glucose-6-phosphatase activity respond to diet?
Yes, it is nutritionally regulated so that endogenous glucose production is suppressed after feeding and activated during fasting.
Can CRISPR be used to study glucose-6-phosphatase activity?
Yes, knockout, point-mutation, knock-in, and overexpression models allow causal testing of glucose-6-phosphatase genes and transporters.
What diseases are linked to glucose-6-phosphatase activity?
Inherited defects cause metabolic and glycogen storage disorders, and altered activity is linked to cancer metabolism and islet dysfunction.
Conclusion
Glucose-6-phosphatase activity (GO:0004346) is the terminal hydrolytic step that releases free glucose from glucose 6-phosphate, and it sits at the center of endogenous glucose production and systemic glucose homeostasis. Its dependence on the microsomal membrane and transport proteins makes it a paradigm for studying how cellular architecture shapes enzyme function. The activity is regulated nutritionally and hormonally and is altered in cancer, inflammation, and islet dysfunction, giving it broad biomedical relevance. CRISPR-based knockout, point-mutation, knock-in, and overexpression models now provide the causal evidence needed to move from correlation to mechanism in this field.
References
- 1. Burchell A. 1990. Molecular pathology of glucose-6-phosphatase.. FASEB J 4(12):2978-88 PMID: 2168325
- 2. Kim MJ et al.. 2019. Glucose-6-phosphatase Expression-Mediated [(18)F]FDG Efflux in Murine Inflammation and Cancer Models.. Mol Imaging Biol 21(5):917-925 PMID: 30719695
- 3. Pan CJ et al.. 1998. Transmembrane topology of glucose-6-phosphatase.. J Biol Chem 273(11):6144-8 PMID: 9497333
- 4. De Vadder F et al.. 2014. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits.. Cell 156(1-2):84-96 PMID: 24412651
- 5. Olsen BB et al.. 2019. Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy.. Mol Imaging Biol 21(2):375-381 PMID: 29987620
- 6. Khan A et al.. 1995. Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone.. Endocrinology 136(5):1934-8 PMID: 7720640
- 7. Mithieux G. 1996. Role of glucokinase and glucose-6 phosphatase in the nutritional regulation of endogenous glucose production.. Reprod Nutr Dev 36(4):357-62 PMID: 8878353
- 8. Zakim D et al.. 1982. The role of the membrane in the regulation of activity of microsomal glucose-6-phosphatase.. J Biol Chem 257(3):1145-8 PMID: 6276375
